Gemcitabine as a single-agent treatment for ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference9 articles.
1. The role of gemcitabine in the treatment of ovarian cancer;Ozols;Semin Oncol,2000
2. Phase II study of gemcitabine in previously platinum-treated ovarian cancer patients;Lund;Anticancer Drugs,1995
3. Activity of gemcitabine in patients with advanced ovarian cancer;Shapiro;Gynecol Oncol,1996
4. A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer;Friedlander;Ann Oncol,1998
5. Phase II study of gemcitabine in ovarian cancer;von Minckwitz;Ann Oncol,1999
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors;Investigational New Drugs;2024-08-03
2. Scrutinizing the therapeutic and diagnostic potential of nanotechnology in thyroid cancer: Edifying drug targeting by nano-oncotherapeutics;Journal of Drug Delivery Science and Technology;2021-02
3. Recent advances and prospects in gemcitabine drug delivery systems;International Journal of Pharmaceutics;2021-01
4. Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance;Cellular Oncology;2020-10-14
5. A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma;Gynecologic Oncology;2020-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3